The goal is to determine whether three months of at least three times / week of sensory flicker stimulation improves cognition, mobility, and affect in healthy older adults and older adults with and without Subjective Cognitive Decline (SCD). Investigators will also determine whether the intervention slows cortical thinning and declines in brain functional network segregation and changes in blood biomarkers of Alzheimer's Disease (AD).
Age range
65 Years – 89 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Cognition
Timeframe: Baseline, halfway through (1.5 months), and post-intervention (3 months)
Grip strength
Timeframe: Baseline, halfway through (1.5 months), and post-intervention (3 months)
10m Gait Speed
Timeframe: Baseline, halfway through (1.5 months), and post-intervention (3 months)
Clinical Test of Sensory Interaction on Balance (CTSIB)
Timeframe: Baseline, halfway through (1.5 months), and post-intervention (3 months)
Affect - POMS-2
Timeframe: Baseline, halfway through (1.5 months), and post-intervention (3 months)
Affect - Ryff Scales of Psychological Wellbeing
Timeframe: Baseline, halfway through (1.5 months), and post-intervention (3 months)
Affect - Satisfaction with Life Scale
Timeframe: Baseline, halfway through (1.5 months), and post-intervention (3 months)
Affect - Perceived Stress Scale
Timeframe: Baseline, halfway through (1.5 months), and post-intervention (3 months)
Affect - Apathy Evaluation Scale
Timeframe: Baseline, halfway through (1.5 months), and post-intervention (3 months)
Affect - TabCAT Dynamic Affect Recognition Test (DART) task
Timeframe: Baseline, midpoint (1.5 months), and post-intervention (3 months)
Affect - TabCAT Social Interaction Vocabulary Test (SIVT) task
Timeframe: Baseline, midpoint (1.5 months), and post-intervention (3 months)
Brain Structure and Network Function
Timeframe: Baseline, halfway through (1.5 months), and post-intervention (3 months)
Blood-based AD pathology (Aβ17)
Timeframe: Baseline, halfway through (1.5 months), and post-intervention (3 months)
Blood-based AD pathology [p-tau]
Timeframe: Baseline, halfway through (1.5 months), and post-intervention (3 months)